Title of study: Cellular signaling pathways modulated by low-intensity extracorporeal shock wave therapy
Authors: Tianshu Liu, Alan W. Shindel, Guiting Lin & Tom F. Lue
Low-intensity extracorporeal shock wave therapy (Li-ESWT) is a non-invasive form of energy transfer that can induce beneficial effects in human tissues. At the appropriate dosing, Li-ESWT can enhance neovascularization, tissue regeneration, and reduce inflammation. This therapy is thought to work by enhancing the expression of specific growth factors and proteins responsible for cellular proliferation, recruitment, and activation of stem/progenitor cells.
Li-ESWT has been studied for managing various musculoskeletal and cardiovascular diseases. It has also been shown to be effective in managing Peyronie’s disease and erectile dysfunction (ED). The mechanism by which Li-ESWT works for ED is not entirely understood, but the current evidence suggests that it enhances penile hemodynamics by promoting angiogenesis and increasing blood flow to the penis.
Being a non-invasive therapy treatment, Li-ESWT has several advantages over traditional treatment methods. It is painless, requires no anesthesia, and has a short recovery time. Additionally, it has been found to be effective in managing chronic conditions that are often difficult to treat using traditional methods.
The study suggests that Li-ESWT is a promising therapy for managing various conditions that involve tissue damage, inflammation, and reduced blood flow. Its non-invasive nature and proven efficacy make it an attractive alternative to traditional treatment methods.
Click here to read more.